tadocizumab Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Treatment of patients undergoing percutaneous coronary interventions.

tadocizumab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

tadocizumab Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
ShangHai Biochempartner Co.,Ltd	177-54423994 17754423994	2853530910@QQ.com	China	8011	62
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10436	58
Biolab Reagents	027-65279366 18108604862	products@biolabreagent.com	China	9818	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 13720134139	orders@jknbiochem.com	China	5821	58
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11974	58
Changsha Fuzhen Biotechnology Co.，LTD	18670069958 18670069958	3062105966@qq.com	China	3262	58
Olix (Shanghai) Pharmaceutical Technology Co., Ltd	17316404525	209533805@qq.com	China	9906	58

---

• tadocizumab
• Research Grade Tadocizumab (DHC33303)
• 339086-80-5